Cyclooxygenase-2 and β-Catenin as Potential Diagnostic and Prognostic Markers in Endometrial Cancer
- 1China-Japan Friendship Hospital, Beijing, China
- 2Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China
- 3Beijing Haidian Center for Disease Control and Prevention, Beijing, China
A Corrigendum on
Cyclooxygenase-2 and β-Catenin as Potential Diagnostic and Prognostic Markers in Endometrial Cancer
by Deng, L., Liang, H., and Han, Y. (2020). Front. Oncol. 10:56. doi: 10.3389/fonc.2020.00056
In the original article, there was a mistake in the Supplementary Table named Table S3 AUCs, Sensitivity, Specificity of cox2, β-catenin and wnt3a in predicting diagnosis, myometrial invasion, vessel invasion, lymph node metastasis, and poor prognosis as published. The specificity of wnt3a in serum for myometrial invasion is 0.316 and the p value is 0.010. The corrected Supplementary Table S3 appears below.
Table S3. AUCs, Sensitivity, Specificity of cox2, β-catenin and wnt3a in predicting diagnosis, myometrial invasion, vessel invasion, lymph node metastasis, and poor prognosis.
An author was incorrectly labeled as Haiyan Liang1, as she is the co-correspondence author. The correct label is Haiyan Liang1*.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: cyclooxygenase-2, β-catenin, wnt3a, endometrial cancer, prognostic marker, diagnostic marker
Citation: Deng L, Liang H and Han Y (2020) Corrigendum: Cyclooxygenase-2 and β-Catenin as Potential Diagnostic and Prognostic Markers in Endometrial Cancer. Front. Oncol. 10:582704. doi: 10.3389/fonc.2020.582704
Received: 13 July 2020; Accepted: 10 September 2020;
Published: 03 November 2020.
Edited and reviewed by: Giuseppe Vizzielli, Catholic University of the Sacred Heart, Italy
Copyright © 2020 Deng, Liang and Han. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lin Deng, ZmxvcmExMDg1QDE2My5jb20=; Haiyan Liang, MTM2MTEzMTEzNjBAMTM5LmNvbQ==